Clinical Trials Logo

Relapsed Brain Tumors clinical trials

View clinical trials related to Relapsed Brain Tumors.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00923468 Completed - Clinical trials for Relapsed Solid Tumors

Pharmacokinetic Studies Participation Survey

Start date: September 23, 2008
Phase: N/A
Study type: Observational

Background: - A pharmacokinetic (PK) study of a new drug involves taking several blood samples over a period of time from study participants to determine how the body handles the substance. These studies provide critical information about new drugs. - Often, patients or parents of children in drug studies choose not to participate in optional PK studies that are part of the study protocol. - A better understanding of why patients or families do or do not agree to participate in PK studies may help researchers make it easier for people to participate in them. Objectives: - To learn why some people do or do not agree to participate in PK blood sampling studies. Eligibility: - Patients 18 years of age and older and parents or guardians of children who are participating in a study of a drug that includes the option of participating in PK sampling. Design: - Participants fill out a 2-page survey asking about why they did or did not participate in the study's PK sampling.